New Study Questions Medical Cannabis for Anxiety and Depression
This medical cannabis anxiety relief study examines the effects of cannabis on anxiety and depression. The findings highlight the need for evidence-based guidance in clinical settings. Clinicians should consider this study when advising patients on…
The media said there’s “no evidence” medical cannabis helps anxiety, depression or PTSD …
Media misinterpretation clinical evidence creates confusion about medical cannabis benefits for anxiety, depression, and PTSD. Emerging studies suggest potential therapeutic effects despite limited FDA approval. Clinicians must understand evidence…
Exploring Cannabinoid Clinical Benefits for Athlete Mental Health
This article reviews cannabinoid clinical benefits athlete mental health, highlighting evidence from clinical trials involving retired professional athletes. It discusses factors influencing mental health post-retirement and the role of cannabinoids.…
Sparse Evidence For Cannabis To Treat Mental Health Conditions Highlights Research Gap
Mental health research gap remains a critical issue in cannabis treatment evidence. Current studies show limited data for cannabis use in anxiety, PTSD, and depression. Clinicians must navigate this gap carefully when advising patients.
Cannabidiol and Escitalopram: Faster Behavioral Effects in Stress Models
CBD SSRI adjunctive therapy shows promise in reducing the latency of antidepressant effects. This preclinical study highlights faster behavioral improvements with combined treatment. The findings suggest potential clinical relevance for mood disorder…
New and Emerging Treatments for Anxiety Disorders
Treatment-resistant anxiety presents a significant clinical challenge requiring novel approaches. Emerging therapies include neuromodulation techniques and natural supplements. This review highlights augmentation strategies for treatment-resistant…
Cannabis and Mental Health: A Review
Cannabis and mental health risk is a critical topic as many use cannabis to manage symptoms despite limited evidence. This review examines the risks and benefits of cannabis in mental health conditions. Understanding cannabis and mental health risk helps…
A Lancet Psychiatry Study Found No Evidence Cannabinoids Treat Anxiety, PTSD
A recent Lancet Psychiatry study reviewed cannabinoid efficacy anxiety PTSD and found insufficient evidence supporting their use. This challenges common clinical practices recommending cannabis for these conditions. The findings highlight the need for…
Lancet Review of Medical Cannabis in Mental Health – What the Study Shows
The Lancet review on mental health cannabis use evidence reveals a significant gap between clinical practice and research. Cannabis is increasingly used by patients with psychiatric disorders despite limited trial data. This review emphasizes the need…
Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.
This study explores cannabinoid pharmacology anxiety and its impact on therapeutic cannabis use for anxiety. It compares daily and longitudinal anxiety reductions between flower and edible cannabis products. Understanding these effects is essential for…
